In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emerging Views On Emerging Markets: Cowen Group Healthcare Conference

This article was originally published in PharmAsia News

Executive Summary

PharmAsia News takes a closer look at presentations referencing emerging markets by Abbott, Amgen, Cardinal Health, Charles River Labs and J&J.

You may also be interested in...



China's Leading CROs Go On Shopping Spree To Become One-Stop Vendors

China's leading contract research organizations, Wuxi PharmaTech and ShangPharma, in a race to win over Big Pharma with integrated service platforms, announced separate deals Oct. 24 to expand into new strategic areas

Cross-Border Pollination? J&J China R&D Center Bonds With Indian Unit For Local Innovation

CHENNAI, India - Having established a device R&D innovation center in Suzhou, China, in July, Johnson & Johnson Medical Ltd. and DePuy, the $5 billion orthopaedics, spinal care and neurosciences franchise of Johnson & Johnson Company, have started working closely with their Indian counterparts in Mumbai to obtain local insights needed to develop products appropriate for the Asian marketplace

J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition

Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC080735

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel